EU consults on future of project for accelerating trials in developing countries
This article was originally published in Scrip
Executive Summary
The European Commission is seeking feedback on the future of an R&D programme that was set up to accelerate the development of new and improved drugs against HIV/AIDS, malaria and tuberculosis. The programme's current focus is on conducting Phase II and III clinical trials in Sub-Saharan Africa.